SemaThera Inc
Advertisement
SemaThera Inc., located in Westmount, QC, is dedicated to developing innovative treatments for diabetic and other retinal degenerative diseases. The company has emerged from over a decade of research led by Professor Przemyslaw Mike Sapieha, focusing on the role of semaphorins, particularly semaphorin 3A, in these conditions.
Through the creation of biological traps designed to bind and sequester semaphorin 3A and related cytokines, SemaThera aims to mitigate the effects of diabetic retinopathy. Their studies have demonstrated the potential of these traps to reduce retinal vascular leakage, inflammation, and promote physiological revascularization in various models of retinal vascular diseases.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement